Drug Information

Drug General Information
Drug ID
D0FS3L
Former ID
DNC013679
Drug Name
4-formylphenyl-O-beta-D-ribopyranoside
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528897]
Structure
Download
2D MOL

3D MOL
Formula
C12H14O6
Canonical SMILES
C1C(C(C(C(O1)OC2=CC=C(C=C2)C=O)O)O)O
InChI
1S/C12H14O6/c13-5-7-1-3-8(4-2-7)18-12-11(16)10(15)9(14)6-17-12/h1-5,9-12,14-16H,6H2/t9-,10-,11-,12+/m1/s1
InChIKey
QGBRWWHJQCFYEI-KKOKHZNYSA-N
PubChem Compound ID
24796254
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [528897]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 528897Eur J Med Chem. 2008 Jan;43(1):166-73. Epub 2007 Apr 5.Synthesis and biological evaluation of helicid analogues as novel acetylcholinesterase inhibitors.
Ref 528897Eur J Med Chem. 2008 Jan;43(1):166-73. Epub 2007 Apr 5.Synthesis and biological evaluation of helicid analogues as novel acetylcholinesterase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.